Publication
Mediaspace scheduled maintenance: Aug 25, 2026 07:00 - 12:00 AM. During this time, videos will be temporarily unavailable. Check status updates.
Lipid nanoparticles (LNPs) are among the most promising drug delivery carriers in research and development, with one major clinical application being messenger RNA (mRNA) vaccine. Current LNP production methods have the limit of generating low polydispersity index (PDI; PDI < 0.1) only for relatively small particles (
Paolo Ricci, Joaquim Loizu Cisquella, Maurizio Giacomin, António João Caeiro Heitor Coelho
Stefano Alberti, Francisco Sanchez
Ambrogio Fasoli, Laurie Porte, Arsène Stéphane Tema Biwole